These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 27897196)
1. Product release is rate-limiting for catalytic processing by the Dengue virus protease. Shannon AE; Pedroso MM; Chappell KJ; Watterson D; Liebscher S; Kok WM; Fairlie DP; Schenk G; Young PR Sci Rep; 2016 Nov; 6():37539. PubMed ID: 27897196 [TBL] [Abstract][Full Text] [Related]
2. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor. Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519 [TBL] [Abstract][Full Text] [Related]
4. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides. Khumthong R; Niyomrattanakit P; Chanprapaph S; Angsuthanasombat C; Panyim S; Katzenmeier G Protein Pept Lett; 2003 Feb; 10(1):19-26. PubMed ID: 12625822 [TBL] [Abstract][Full Text] [Related]
5. NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues. El Sahili A; Soh TS; Schiltz J; Gharbi-Ayachi A; Seh CC; Shi PY; Lim SP; Lescar J J Virol; 2019 Dec; 94(1):. PubMed ID: 31597763 [TBL] [Abstract][Full Text] [Related]
6. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study. Yotmanee P; Rungrotmongkol T; Wichapong K; Choi SB; Wahab HA; Kungwan N; Hannongbua S J Mol Graph Model; 2015 Jul; 60():24-33. PubMed ID: 26086900 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain. Shannon AE; Chappell KJ; Stoermer MJ; Chow SY; Kok WM; Fairlie DP; Young PR Protein Expr Purif; 2016 Mar; 119():124-9. PubMed ID: 26647367 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the West Nile virus protease substrate specificity and inhibitors. Mueller NH; Yon C; Ganesh VK; Padmanabhan R Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006 [TBL] [Abstract][Full Text] [Related]
10. A comparative biochemical analysis of the NS2B(H)-NS3pro protease complex from four dengue virus serotypes. Iempridee T; Thongphung R; Angsuthanasombat C; Katzenmeier G Biochim Biophys Acta; 2008; 1780(7-8):989-94. PubMed ID: 18439431 [TBL] [Abstract][Full Text] [Related]
11. Dengue Protease Substrate Recognition: Binding of the Prime Side. Lin KH; Nalivaika EA; Prachanronarong KL; Yilmaz NK; Schiffer CA ACS Infect Dis; 2016 Oct; 2(10):734-743. PubMed ID: 27657335 [TBL] [Abstract][Full Text] [Related]
12. Allosteric inhibition of the NS2B-NS3 protease from dengue virus. Yildiz M; Ghosh S; Bell JA; Sherman W; Hardy JA ACS Chem Biol; 2013 Dec; 8(12):2744-52. PubMed ID: 24164286 [TBL] [Abstract][Full Text] [Related]
13. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side. Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA J Virol; 2017 May; 91(10):. PubMed ID: 28298600 [TBL] [Abstract][Full Text] [Related]
14. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds. Leonel CA; Lima WG; Dos Santos M; Ferraz AC; Taranto AG; de Magalhães JC; Dos Santos LL; Ferreira JMS Arch Virol; 2018 Mar; 163(3):575-586. PubMed ID: 29147793 [TBL] [Abstract][Full Text] [Related]
15. Zika virus NS3 is a canonical RNA helicase stimulated by NS5 RNA polymerase. Xu S; Ci Y; Wang L; Yang Y; Zhang L; Xu C; Qin C; Shi L Nucleic Acids Res; 2019 Sep; 47(16):8693-8707. PubMed ID: 31361901 [TBL] [Abstract][Full Text] [Related]
16. Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. Brinkworth RI; Fairlie DP; Leung D; Young PR J Gen Virol; 1999 May; 80 ( Pt 5)():1167-1177. PubMed ID: 10355763 [TBL] [Abstract][Full Text] [Related]
17. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction. Wichapong K; Pianwanit S; Sippl W; Kokpol S J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793 [TBL] [Abstract][Full Text] [Related]
18. Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease. de la Cruz L; Chen WN; Graham B; Otting G FEBS J; 2014 Mar; 281(6):1517-33. PubMed ID: 24472363 [TBL] [Abstract][Full Text] [Related]
19. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease. Velmurugan D; Mythily U; Rao K Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design. Murthy HM; Judge K; DeLucas L; Padmanabhan R J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]